NL-OMON21516招募中不适用
Improving practicality of radiofrequency ablation for eradication of Barrett's mucosa: A randomized trial comparing three different treatment regimens for circumferential ablation using the HALO360 System.
AMC Amsterdam0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Scheduled HALO360 ablation for BE with flat low-grade dysplasia (LGD) or high-grade dysplasia (HGD) or for BE (with or without neoplasia) after prior endoscopic resection (ER) for lesions containing HGD or and early cancer;
- •2. Review of histopathology specimens by a local expert pathologist;
排除标准
- •1. In case of prior ER: A specimen showing carcinoma with positive vertical resection margins, deep submucosal invasion (≥ T1sm2), poorly or undifferentiated cancer (G3 or G4), or lymphatic/vascular invasion;
- •2. Patients unable to give informed consent.
研究者
相似试验
招募中
不适用
Improving practicality of radiofrequency ablation for eradication of Barrett's mucosa: A randomized trial comparing two different treatment regimens for focal ablation using the HALO90 System.Barrett's esophagusearly Barrett's neoplasiaBarrett's dysplasiaradiofrequencty ablationIntestinal metaplasiaIntraepithelial neoplasiaNL-OMON24115AMC Amsterdam46
已完成
2 期
Improving practicality of radiofrequency ablation for eradication of Barrett*s mucosa: a randomized trial comparing two different treatment regimens for focal ablation using the HALO90 SystemDysplasia in Barrett'sprecancerous esophageal mucosa10017990NL-OMON35335Academisch Medisch Centrum64
已完成
不适用
Improving practicality of radiofrequency ablation for eradication of Barrett*s mucosa: a randomized trial comparing two different treatment regimens for circumferential ablation using the HALO360 SystemBarrett's esophagusearly cancer10017990NL-OMON32766Academisch Medisch Centrum36
终止
不适用
Quality of Life in Patients Post Radiofrequency AblationRadiofrequency Catheter AblationQuality of LifeArrhythmiaNCT00165997Emory University50
撤回
不适用
RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell CarcinomaRenal Cell CarcinomaNCT00601120Beth Israel Deaconess Medical Center